Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	51.8	28.8	24.8	17.0	20.5	29.3	59.3	71.3	55.0	31.1	25.4	26.0	36.8	47.7	81.2	41.0	20.1	36.1	17.4	24.3	16.5	68.7	15.6	28.8	39.2	22.4	33.4	41.8	56.3	35.4	25.9	37.6	29.9	35.7	36.4	33.8	21.9	39.6	40.2	21.3	39.0	11.3	23.6	40.3	11.1	36.3	22.0	46.0	17.4	26.9	10.8	28.9	74.3	32.1	27.6	27.1	32.2	37.4	81.1	45.4	23.6	50.8	68.6	47.2	52.1	32.7	35.8	30.2	34.9	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5	348.4	174.9	170.6	139.1	221.2	29.2	25.0	142.7	81.7	120.6	78.5	13.7	419.1	140.9	316.3	26.2	168.2	202.4	0.0	245.8	625.6	206.8	137.2	247.7	72.7	547.8	36.5	193.8	182.3	533.2	18.6	116.5	649.2	241.3	607.8	124.2	50.0	287.4	192.9	172.5	110.5	24.5	239.3	277.9	83.0	95.6	214.0	166.8	309.6	117.5	206.4
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.2;RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	2.0	1.5	1.9	2.2	2.8	2.7	1.0	1.9	2.0	2.2	2.1	1.2	2.5	6.9	2.5	1.5	2.2	1.9	1.8	2.0	3.8	3.5	1.8	4.5	1.3	2.0	1.2	9.1	3.1	1.4	1.5	1.3	0.6	2.2	1.5	5.0	4.7	5.0	1.8	3.1	4.9	15.2	1.7	3.4	3.7	3.2	49.9	2.9	1.8	2.6	1.2	1.8	3.1	2.9	1.6	0.9	5.0	8.6	0.8	1.7	2.9	2.2	1.9	4.1	2.1	3.6	1.8	9.8	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	11.7	14.9	5.1	0.0	0.0	0.0	0.0	9.4	11.6	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.8	0.0	0.0	4.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.5	1.9	6.2	3.7	9.3	5.6	4.9	7.1	6.5	9.4	8.3	4.3	4.4	15.5	1.6	3.8	6.1	3.1	3.4	6.5	10.5	5.5	4.2	9.7	8.6	4.9	6.6	12.4	3.6	5.4	9.4	7.8	5.5	8.3	5.9	7.9	9.0	2.4	7.2	4.5	9.9	7.9	10.1	4.7	7.7	3.3	5.3	8.3	5.6	1.9	2.3	4.3	8.6	5.5	5.3	5.5	1.9	5.4	3.2	7.0	5.5	6.5	9.6	5.0	5.3	8.3	5.2	14.2	5.5	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9	20.8	19.9	24.5	21.3	25.0	66.8	26.9	25.5	57.6	35.2	21.0	102.1	17.7	24.9	17.3	158.6	28.7	8.0	23.3	9.1	11.3	30.0	13.3	33.5	7.5	16.2	49.3	20.2	27.0	26.2	74.4	50.0	20.8	25.3	43.3	9.4	34.0	13.6	10.2	44.9	16.5	99.9	32.3	30.2	49.7	45.4	25.7	13.7	47.3	13.6	9.5
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500180-99604026	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	3.5	12.0	13.9	3.3	15.5	7.2	6.1	45.2	11.8	11.3	15.3	11.7	16.6	15.4	8.7	12.6	24.0	10.0	13.9	11.4	11.6	7.6	7.8	32.3	6.7	1.9	10.3	5.9	6.9	15.3	10.4	10.0	7.1	9.1	15.8	9.5	19.9	20.8	14.8	15.2	13.6	27.0	15.4	8.4	3.0	10.5	8.1	8.1	2.7	9.5	9.3	8.7	13.7	17.9	0.3	0.1	0.7	0.0	0.4	2.0	0.6	17.5	16.1	20.0	12.0	0.2	0.0	18.6	5.9	6.1	12.0	7.0	19.5	18.7	0.1	23.7	6.7	3.3	23.7	14.7	14.3	7.5	28.8	8.7	0.9	16.0	13.1	1.6	0.2	1.9	0.0	7.6	3.4	9.9	7.1	3.7	10.5	4.2	2.7	1.4	29.4	7.8	2.4	7.3	20.3	16.8	11.7	8.4	3.9	8.5	7.0	9.9	12.5	15.2	8.1	3.7	8.0	17.7	3.6	8.4	2.3	20.0	8.5	5.9	4.2	5.5	0.1	0.4	1.5	1.6	0.7	0.0	0.0	0.6	0.0	0.8	0.2	1.9	1.3	0.0	0.3	2.0	1.1	0.6	0.4	0.0	0.1	2.0	0.6	13.9	15.5	45.2	11.8	11.6	7.6	10.3	5.9	9.1	8.1	20.8	6.4	0.9	7.8	7.8	31.0	2.2	7.6	2.7	9.1	1.8	58.9	5.4	0.0	7.3	2.3	4.2	14.2	0.0	8.1	3.5	2.3	8.5	5.8	15.3	1.6	1.6	9.2	6.2	1.2	0.9	0.6	0.6	8.5	0.0	9.6	28.9	11.9	14.0	0.7	5.1	47.8	0.0	2.3	0.9	1.6	12.3	4.1	0.7	10.9	10.3
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238940-203305611	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"		No	No			"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: AB_2682951, HPA058461: AB_2683725"	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	11.1	14.9	5.0	9.1	6.4	2.8	7.6	6.8	6.1	9.3	8.6	8.6	9.2	6.0	10.8	7.1	8.0	8.0	9.1	7.0	4.5	4.8	13.5	12.5	8.4	7.8	8.1	2.1	13.4	17.3	9.1	13.6	9.4	6.5	9.0	7.8	10.9	9.8	8.8	5.3	6.3	10.5	9.0	6.5	10.1	8.8	10.8	8.1	13.8	16.9	4.3	9.1	7.7	9.7	13.0	13.6	6.8	11.3	8.8	15.5	9.1	5.2	4.9	2.5	4.9	14.6	3.1	5.2	8.9	4.5	3.8	3.9	14.1	7.6	3.8	7.3	5.6	6.4	5.8	3.2	4.0	5.3	5.1	3.8	8.2	3.1	6.4	11.3	9.0	5.2	6.9	3.1	6.1	6.4	2.8	7.5	7.0	12.7	13.1	6.9	7.1	7.5	4.7	9.7	3.8	10.9	5.1	5.7	7.4	4.5	10.4	3.7	5.1	0.3	4.6	7.3	4.6	2.8	4.9	8.5	12.3	4.8	6.1	5.6	8.9	9.7	4.6	7.6	3.6	5.7	5.2	10.4	6.8	14.4	11.3	15.5	11.1	14.9	12.7	7.8	13.0	12.5	9.2	2.2	8.8	10.5	13.6	13.4	9.1	5.0	6.4	6.8	6.1	4.5	4.8	8.1	2.1	6.5	8.1	14.9	28.6	32.8	34.8	11.0	38.9	22.7	35.7	28.1	43.3	15.7	55.0	28.0	10.0	15.4	79.1	37.9	32.7	23.3	17.9	19.0	33.8	32.0	27.8	42.9	33.5	47.7	43.6	74.3	32.1	14.0	113.9	25.8	6.8	21.6	29.9	37.0	13.8	28.1	78.8	22.1	69.0	64.7	26.8	43.2	28.1	11.7	34.1	33.1	28.6	27.5
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	25.3	22.8	21.3	21.7	15.5	18.0	16.0	18.9	14.5	18.0	18.5	22.4	24.8	35.3	32.4	19.8	17.8	19.1	28.8	24.2	34.9	33.6	20.5	48.7	13.7	25.4	17.7	19.9	21.0	14.6	16.7	26.5	44.1	11.3	24.9	24.3	32.7	15.5	27.3	20.6	37.8	21.0	32.6	71.8	35.6	24.6	25.9	36.3	26.2	21.2	27.2	25.8	11.8	18.5	21.4	19.6	28.6	13.7	16.4	18.3	29.5	23.6	25.3	17.1	29.8	49.9	24.7	43.6	23.4	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0	14.9	14.2	31.8	57.7	70.6	19.2	17.3	7.6	14.7	31.8	31.4	23.6	50.1	33.2	41.0	33.6	28.9	16.1	0.0	42.0	61.5	36.1	25.3	40.3	14.7	39.5	15.9	13.9	17.2	15.4	10.8	22.5	25.0	25.3	30.7	16.0	25.8	34.4	10.5	16.6	66.3	19.8	12.9	36.3	85.0	87.9	67.2	28.4	26.3	25.4	52.2
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.2;SuSa: 10.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.6	2.0	17.2	0.0	0.0	0.0	6.3	2.2	1.5	1.6	3.0	0.0	2.0	0.0	6.2	2.4	3.2	0.8	5.7	2.4	1.3	0.0	4.2	0.0	3.9	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.4	2.5	3.7	0.0	0.0	0.0	4.7	1.4	0.0	0.0	7.3	0.4	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	10.1	1.8	0.0	0.3	7.1	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5	6.0	5.3	1.4	0.1	1.6	15.3	16.8	10.2	6.7	3.4	12.2	0.0	18.1	1.7	2.5	2.7	0.7	0.0	0.0	1.3	5.9	6.3	0.9	0.0	11.3	1.2	6.4	0.0	7.4	0.0	4.2	48.1	0.2	16.9	0.0	0.0	6.5	1.7	0.0	32.2	6.3	1.9	71.1	13.9	0.2	0.6	0.4	14.1	0.0	0.0	0.0
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell type enriched"	"Detected in many"	5	"monocytes: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.7	2.7	0.8	2.2	0.7	0.7	4.4	1.5	1.0	1.2	1.7	2.1	1.8	0.6	1.9	1.5	1.6	10.1	2.4	1.0	1.8	13.1	4.0	0.0	7.8	3.2	2.7	0.0	1.1	0.7	2.1	2.1	1.3	1.2	1.0	2.0	0.7	17.3	0.5	3.4	1.9	1.0	0.9	2.3	3.4	0.3	0.7	2.3	0.8	3.2	1.2	3.3	5.8	34.0	2.8	1.7	4.8	0.6	7.1	4.3	1.1	11.1	0.7	16.7	2.7	0.0	3.2	6.7	1.8	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8	6.0	9.9	0.5	6.4	12.0	0.2	12.1	5.1	2.7	6.8	5.2	2.0	25.6	0.0	3.0	0.0	2.9	5.6	0.0	3.3	9.1	3.8	4.4	0.0	12.9	3.8	1.6	0.0	0.0	1.2	0.0	1.7	4.5	6.8	184.0	4.3	1.4	9.2	4.8	4.9	1.4	1.5	0.0	3.9	0.5	2.5	21.2	40.3	2.1	4.3	13.7
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6"	"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.9	5.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	9.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	86.8	58.3	0.0	0.0	0.0	34.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4	0.0	0.0	0.0	2.6	0.1	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	253.7	1.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.4	0.0	0.0	4.1	63.3	4.8	36.6	2.6	0.0	0.0	1.0	0.0	0.0	5.5	0.0	4.6	0.0	0.0	0.0	0.2	64.6	2.1	0.0	0.0	0.0	0.0	2.5
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	9.4	0.0	3.0	1.3	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.6	7.5	0.1	0.2	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.5	11.2	0.1	0.5	0.6	17.0	0.0	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	5.8	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7	0.0	14.3	0.0	1.0	2.3	0.8	13.2	2.5	0.0	5.7	1.8	0.0	0.2	0.0	0.1	0.9	18.0	0.0	0.0	0.0	0.2	3.2	0.2	5.8	0.2	2.2	0.0	0.0	62.0	24.9	3.1	38.3	1.3	3.3	0.0	0.0	0.5	0.0	0.0	70.4	0.0	0.0	0.0	3.3	0.5	0.9	1.5	0.2	0.0	0.0	0.3
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 69.3;Late spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.3	4.5	9.3	9.1	0.2	0.2	2.1	2.0	2.3	4.4	5.4	1.9	3.8	0.0	2.0	0.4	7.7	4.2	12.0	3.9	3.9	0.6	7.6	0.1	7.0	1.7	1.6	1.2	0.2	1.0	7.1	3.9	5.0	5.4	0.1	4.0	2.9	0.1	0.5	2.4	3.6	2.6	0.4	1.9	1.1	1.4	0.4	0.0	10.1	0.8	28.4	9.9	3.6	8.6	2.6	6.6	8.6	1.3	0.0	0.6	2.2	1.3	2.9	4.2	9.4	0.0	1.8	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9	6.0	2.4	0.0	4.2	8.7	17.4	2.6	5.1	16.0	3.4	3.5	25.5	1.9	5.0	4.7	69.3	1.1	0.4	0.0	2.5	1.3	0.9	3.6	1.1	5.0	0.4	11.1	8.1	0.0	0.0	54.0	2.6	0.2	3.3	0.0	1.0	5.0	3.7	1.4	0.4	9.4	15.7	6.5	1.0	21.6	12.4	7.5	0.6	0.0	1.0	1.4
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.9	2.8	2.1	21.1	11.9	2.9	12.4	6.4	6.8	16.9	12.5	3.8	0.0	1.4	14.3	2.9	0.2	1.6	3.2	2.8	5.1	1.1	3.7	1.1	2.4	30.4	0.0	0.3	42.6	0.0	31.3	0.2	4.0	3.3	0.0	0.0	0.0	8.8	2.1	0.0	0.0	5.5	3.8	0.7	0.0	9.4	0.0	6.3	1.1	0.1	7.1	2.0	10.3	6.4	8.4	13.4	0.0	1.6	6.9	13.8	27.6	8.3	1.7	1.9	0.8	1.4	0.9	8.8	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3	8.9	15.4	0.0	47.6	28.0	13.3	13.7	20.4	20.1	15.9	5.2	9.8	2.6	3.3	99.6	0.9	70.2	0.5	0.0	42.3	3.5	58.2	6.1	10.3	11.3	3.1	92.2	11.6	36.2	0.6	1.5	10.6	4.0	50.6	15.4	2.2	34.8	83.3	0.0	30.4	29.2	7.9	0.0	171.0	5.0	7.0	23.7	3.7	2.2	3.3	5.2
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	3.8	0.0	2.5	0.0	1.0	0.4	7.4	9.3	0.1	0.0	0.7	9.8	2.4	1.4	0.4	1.1	0.0	0.1	1.7	8.1	0.2	0.0	1.0	0.0	0.9	1.9	9.9	0.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.3	0.0	4.7	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.6	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8	3.0	1.6	0.0	0.9	0.3	5.3	2.8	0.0	144.6	15.9	5.2	35.3	0.2	1.7	0.5	74.2	1.5	0.0	0.0	0.2	0.2	3.2	0.7	1.1	0.0	2.2	11.1	4.1	11.1	0.3	23.5	9.8	1.7	0.0	6.4	0.5	6.0	0.2	0.0	9.9	3.2	18.6	0.0	1.7	29.6	8.6	0.3	0.5	0.7	0.1	0.3
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 98.5;Late spermatids: 64.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	64.1	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	8.8	0.9	0.0	0.1	0.0	0.0	0.0
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 78.9;Late spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	13.0	20.5	6.2	8.1	5.2	7.8	15.7	8.6	4.4	5.5	6.2	27.9	7.5	7.7	15.9	5.5	6.4	7.2	5.0	7.0	2.3	9.6	28.7	6.9	18.2	18.2	11.1	7.6	10.0	8.5	4.0	8.3	5.2	3.9	10.9	5.9	10.7	4.4	2.9	18.3	9.3	19.3	13.6	8.2	24.0	15.1	4.8	7.8	7.1	20.0	11.0	12.1	4.8	7.4	8.6	4.7	4.7	8.4	16.8	10.1	8.7	19.5	12.9	8.3	10.0	7.8	11.6	12.2	11.8	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1	3.0	6.9	9.5	12.3	9.2	10.0	4.8	10.2	0.0	4.5	3.5	7.9	17.5	3.3	18.4	78.9	12.8	21.7	0.0	14.9	13.7	10.1	12.1	10.3	3.9	23.4	38.1	19.5	25.8	19.1	220.0	20.8	18.7	1.7	16.2	12.9	7.8	17.9	14.0	29.7	5.2	5.9	12.9	11.4	16.3	26.4	2.9	28.3	10.9	13.1	12.3
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.5	14.1	20.6	11.4	12.5	16.3	33.8	13.0	15.7	12.3	10.4	20.5	21.0	22.1	19.8	12.5	5.7	13.9	15.8	27.8	9.9	17.0	11.8	18.0	12.0	25.2	15.3	20.8	16.5	14.7	17.9	13.8	20.8	15.6	13.0	9.9	15.3	24.6	14.4	26.5	13.3	37.2	35.9	20.1	7.3	12.0	8.2	25.3	25.2	25.0	13.9	16.0	16.6	22.3	11.6	20.0	27.1	44.1	10.1	7.4	10.5	11.5	9.4	13.0	19.7	34.1	12.7	14.5	11.6	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1	17.9	15.9	15.9	26.4	0.0	13.6	0.0	28.1	30.8	26.1	22.7	7.9	72.4	66.3	34.7	9.6	12.4	38.3	23.3	44.0	61.6	11.5	34.5	17.4	32.7	48.8	6.4	7.0	19.0	44.8	7.4	21.6	40.2	0.0	146.1	41.7	34.7	43.4	37.0	22.3	44.1	10.6	12.9	0.0	18.1	24.3	0.0	51.8	37.4	37.7	28.0
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 79.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.7	18.3	11.3	12.4	6.2	5.3	25.8	8.6	4.0	11.6	14.8	7.8	10.2	9.3	12.8	5.9	15.3	6.0	15.1	12.2	21.6	22.6	31.3	13.1	20.6	29.4	6.1	16.8	11.7	3.2	11.0	12.9	10.5	6.2	12.9	15.6	20.3	12.8	9.9	79.0	23.8	23.4	3.0	10.5	17.0	15.3	17.9	17.5	7.0	9.9	14.0	13.0	6.9	3.4	13.0	3.0	10.2	17.8	4.1	9.8	26.0	8.8	10.5	12.0	44.5	27.2	9.9	16.6	11.2	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7	17.9	11.5	15.2	17.6	10.5	14.6	54.1	10.2	10.7	13.6	15.7	5.9	46.3	49.7	22.6	78.9	14.9	4.2	70.0	16.3	78.6	13.4	14.4	23.0	12.5	29.2	15.9	6.4	14.1	13.4	51.1	16.1	22.9	23.6	22.6	13.1	21.7	12.0	10.5	14.5	19.5	23.0	32.3	22.1	113.9	80.6	9.4	30.3	21.3	12.5	8.4
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	2.0	3.9	6.1	0.3	1.4	0.2	0.3	0.6	1.2	1.6	0.2	0.0	0.7	0.2	1.3	0.0	0.8	0.9	0.9	12.2	0.0	0.0	0.0	12.7	6.5	0.8	0.0	4.5	0.0	0.6	0.0	3.7	0.9	0.5	0.0	21.5	0.9	0.0	0.9	13.9	0.4	0.0	0.4	2.6	54.6	17.8	0.1	0.3	0.3	0.3	0.0	0.1	0.6	3.7	0.3	10.6	0.2	0.1	1.2	1.0	2.1	0.2	0.2	0.0	6.4	27.9	18.1	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5	17.9	15.0	4.7	1.2	3.3	17.2	38.7	38.2	6.7	10.3	15.7	3.9	0.9	14.9	40.8	1.2	4.7	11.8	0.0	3.4	1.1	7.0	1.3	1.1	15.5	128.5	35.0	11.1	8.0	63.6	3.2	9.8	81.9	8.5	389.5	8.7	247.8	4.1	14.0	2.1	98.2	13.3	25.8	17.6	0.3	0.9	1.5	2.2	6.4	16.6	0.5
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridylate synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	9.5	9.7	12.0	16.5	14.8	20.9	10.4	15.3	23.8	7.4	11.2	9.4	6.2	17.6	10.5	14.0	13.9	8.6	11.2	8.1	12.7	10.4	10.7	13.4	8.2	18.2	9.5	11.3	10.0	15.3	9.9	8.9	8.2	11.2	11.3	5.1	10.9	19.8	10.5	11.1	16.8	12.8	8.3	7.0	17.4	15.1	6.2	9.2	15.5	8.5	15.1	15.6	10.8	10.7	17.3	23.1	17.7	19.9	18.0	20.4	15.8	10.6	12.6	3.1	14.0	2.7	3.2	14.4	8.9	5.1	11.7	8.5	29.3	10.1	14.9	9.7	4.2	8.2	18.3	7.1	9.0	2.1	13.5	29.0	7.3	19.3	10.5	4.4	13.5	12.4	4.8	8.7	10.1	2.7	3.4	8.0	8.8	17.1	6.7	4.0	33.8	16.8	14.1	15.8	4.9	21.8	30.0	8.3	30.6	4.2	6.6	16.3	11.7	10.2	16.8	9.8	1.9	8.6	16.9	9.0	11.7	15.2	12.2	12.8	10.8	10.8	17.1	5.6	10.6	9.5	17.5	19.9	17.7	18.3	18.0	18.1	14.9	15.5	20.4	23.1	17.3	16.2	16.3	12.7	18.0	17.4	21.2	18.7	15.8	12.0	14.8	15.3	23.8	12.7	10.4	9.5	11.3	11.2	9.2	3.0	3.5	18.7	3.5	14.2	38.1	3.3	2.5	2.7	0.0	8.7	2.0	17.7	6.6	13.7	0.4	6.8	18.6	0.0	23.3	22.4	8.9	4.4	0.0	4.0	17.2	1.6	12.7	10.4	1.6	1.4	6.4	7.9	13.5	23.4	11.0	7.8	22.5	14.0	6.0	8.1	3.3	12.9	5.6	4.2	12.0	14.6	12.2	10.2	16.7	4.7
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	11.1	0.0	0.1	0.0	0.0	84.7	0.0	120.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	179.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	129.5	0.1	0.0	0.0	0.2	0.6	4.0	0.0	0.0	0.1	126.4	0.1	3.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6	56.6	133.0	0.5	298.4	2079.3	0.0	4.4	214.0	18.7	91.0	33.2	0.0	0.6	41.4	164.9	0.0	0.2	1153.1	0.0	59.6	1.7	22.4	341.3	28.7	5.8	0.3	0.0	147.3	1.3	0.0	0.0	0.0	5.3	229.5	3.6	470.4	0.0	202.6	775.0	0.0	3.1	0.0	0.0	33.3	0.0	0.0	3157.3	0.2	0.7	410.3	819.7
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 11.3;Horizontal cells: 14.3"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.5	17.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.1	4.0	0.1	20.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	59.6	0.0	0.0	0.0	2.6	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3	6.0	1.7	0.0	4.6	0.3	4.2	11.3	0.0	4.0	3.4	3.5	2.0	1.0	0.0	0.2	0.0	4.6	0.0	0.0	0.2	0.4	0.6	0.5	0.0	0.5	0.2	14.3	0.0	1.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.9	0.0	0.0	0.7	0.5	0.0	1.8	0.0	0.4	0.5	0.7	0.0	0.0	1.4
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.6	15.1	6.9	8.8	2.5	3.3	11.7	10.5	3.0	4.9	4.1	6.6	12.2	7.4	12.8	3.1	2.8	19.5	3.7	14.1	0.9	8.2	20.8	10.3	13.0	11.6	5.7	4.3	5.8	2.8	13.7	4.7	4.1	2.2	5.3	8.1	13.0	2.6	3.7	37.2	11.1	9.2	5.2	11.6	19.2	13.4	6.4	8.2	2.5	18.8	15.1	11.1	11.9	13.1	11.1	2.2	16.5	10.3	10.2	5.4	22.4	9.5	14.7	9.3	9.1	7.5	5.5	4.3	8.4	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4	0.0	6.9	6.9	4.2	7.6	11.1	10.8	15.3	1.4	1.2	14.0	13.7	8.9	3.3	7.5	1.2	6.0	18.4	23.3	8.1	5.3	5.1	8.0	0.0	7.5	5.5	4.8	13.3	4.3	6.3	0.4	8.3	4.6	8.5	4.6	19.5	11.9	9.9	20.1	9.2	4.3	14.0	12.9	4.2	7.9	9.2	9.4	4.2	5.1	19.5	5.9
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	12.1	0.7	0.2	2.8	19.4	0.0	0.0	1.5	0.5	0.1	2.2	4.1	0.8	0.3	2.2	2.8	1.4	2.4	2.4	0.3	6.7	18.7	0.3	0.1	0.3	0.0	16.4	1.2	0.8	8.2	3.3	1.4	0.0	6.2	0.0	6.1	6.1	7.9	2.8	0.1	3.9	2.9	5.2	3.7	3.8	0.0	1.8	19.4	18.3	4.5	0.8	6.3	0.7	4.4	2.6	0.0	0.1	1.7	7.1	0.0	0.8	6.9	5.1	3.7	4.0	1.4	13.4	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1	3.0	2.9	0.8	40.5	74.4	1.2	1.1	2.5	0.0	18.2	0.0	2.0	7.6	0.0	1.5	10.0	15.8	0.0	0.0	0.6	25.1	7.6	16.1	23.1	3.6	8.2	69.9	5.2	50.3	22.7	9.0	31.9	28.4	10.1	18.0	0.3	39.3	1.1	10.7	54.8	0.0	4.4	6.5	2.1	1.4	6.1	125.3	8.9	6.9	0.9	72.7
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.3	26.1	19.1	17.4	17.3	12.5	17.1	20.2	16.5	18.9	16.2	24.6	22.3	22.3	14.0	17.7	33.7	21.1	46.7	28.0	25.2	29.0	23.1	18.2	19.5	19.2	10.7	31.4	19.0	11.6	15.4	26.3	27.2	14.9	13.1	18.8	18.5	16.7	19.2	37.4	23.9	24.8	30.4	18.4	29.7	21.5	35.6	18.9	20.1	18.1	24.2	16.8	38.5	19.3	21.4	34.7	39.2	11.0	17.9	13.9	24.5	29.1	17.2	17.9	27.0	26.7	20.4	25.0	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5	23.8	23.8	40.1	37.8	29.1	55.8	44.8	22.9	45.5	39.8	33.2	25.5	86.7	106.1	35.8	0.8	36.5	26.0	0.0	28.8	60.7	42.6	34.1	43.9	22.9	39.7	54.0	17.4	23.4	12.3	2.1	32.2	27.9	38.8	70.3	30.8	56.3	30.9	28.6	42.5	51.9	48.8	45.3	43.4	12.2	43.7	27.7	63.5	41.1	28.8	29.1
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.8	6.4	11.3	7.4	11.8	16.5	9.7	8.8	6.8	8.9	5.4	7.5	12.7	13.5	4.7	12.6	5.7	10.8	8.9	10.6	10.0	10.0	8.6	15.8	10.1	6.7	14.0	21.2	17.2	11.5	20.9	6.1	10.0	10.0	9.0	17.6	11.6	11.9	17.2	4.9	15.4	21.3	10.7	15.1	3.3	16.2	6.4	8.2	15.7	10.0	5.8	12.2	6.2	14.9	13.4	13.8	8.7	35.4	14.0	5.8	6.9	5.7	9.9	8.9	11.1	14.3	5.9	15.0	13.3	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8	77.4	38.5	35.3	43.5	38.0	114.4	71.9	38.2	33.5	47.8	31.4	113.9	51.3	58.0	31.0	1.2	57.1	58.8	0.0	25.7	34.0	26.8	47.9	42.8	49.9	37.6	49.3	47.8	33.7	36.4	1.9	46.1	34.1	27.0	27.9	56.5	33.0	27.4	59.4	49.1	58.0	249.2	45.3	28.3	8.4	18.5	50.8	31.9	37.6	49.4	40.0